Talaromyces marneffei causes fatal invasive mycosis in Southeast Asia. Diagnosis by culture has limited sensitivity and can result in treatment delay. We describe the use of a novel Mp1p enzyme immunoassay (EIA) to identify blood culture-negative talaromycosis, subsequently confirmed by bone marrow cultures. This EIA has the potential to speed diagnosis, enabling early therapy initiation.
Keywords: Mp1p EIA; Penicillium marneffei; Talaromyces marneffei; penicilliosis; talaromycosis.
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.